Procoagulant activity in bronchoalveolar lavage in the adult respiratory distress syndrome. Contribution of tissue factor associated with factor VII.
Alveolar fibrin deposition commonly occurs in the lungs of patients with the adult respiratory distress syndrome (ARDS). Bronchoalveolar lavage (BAL) from patients with ARDS, control patients with interstitial lung disease (ILD), congestive heart failure, or exposure to hyperoxia, and normal healthy subjects was studied to determine whether local alterations in procoagulant activity favor alveolar fibrin deposition in the lungs in ARDS. Procoagulant activity capable of shortening the recalcification time of plasma deficient in either factor VII or factor VIII was observed in unconcentrated BAL of all patients, but was significantly greater in BAL from patients with ARDS when compared with that of control subjects (p less than 0.001). Unconcentrated BAL from patients with ARDS shortened the recalcification time of plasma deficient in factor X, but no functional thrombin was detectable. BAL procoagulant from patients with ARDS was inhibited by concanavalin A, an inhibitor of tissue factor. The hydrolysis of purified human factor X by BAL from the ARDS and other patient groups was determined by measuring the amidolytic activity of generated factor Xa on its N-benzoyl-L-isoleucyl-L-glutamyl-glycyl-L-arginine-p-nitroanilide substrate. The procoagulant activity of BAL was associated with the development of amidolytic activity, indicating activation of factor X. BAL from patients with ARDS contained more factor X activating activity than did BAL from control groups (p less than 0.001). This activity was calcium dependent and was maximal at 1 mM ionized calcium. The BAL factor X activating activity was most active at neutral pH and was sedimented by ultracentrifugation at 100,000 x g.(ABSTRACT TRUNCATED AT 250 WORDS)
University of Texas Health Center at Tyler 75710.
S
S
Idell
K
K
Gonzalez
H
H
Bradford
C K
CK
MacArthur
A M
AM
Fein
R J
RJ
Maunder
J G
JG
Garcia
D E
DE
Griffith
J
J
Weiland
T R
TR
Martin
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001777:Blood Coagulation; D001780:Blood Coagulation Tests; D001992:Bronchoalveolar Lavage Fluid / Q000032:analysis* / Q000166:cytology; D005167:Factor VII / Q000032:analysis / Q000502:physiology*; D005170:Factor X / Q000032:analysis / Q000502:physiology; D006333:Heart Failure / Q000097:blood; D006801:Humans; D008171:Lung Diseases / Q000097:blood; D008875:Middle Aged; D010100:Oxygen / Q000008:administration & dosage; D011658:Pulmonary Fibrosis / Q000097:blood; D012128:Respiratory Distress Syndrome / Q000097:blood*; D012507:Sarcoidosis / Q000097:blood; D013925:Thromboplastin / Q000032:analysis / Q000502:physiology*
D005167:Factor VII; D005170:Factor X; D013925:Thromboplastin; D010100:Oxygen